Skip to main content
Log in

Comparative analysis of lung cancer with features of bronchioloalveolar carcinoma and other types of adenocarcinoma

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

The aim of this study was to investigate the clinicopathologic and prognostic factors of the partial subtypes of lung adenocarcinoma, including pure bronchioloalveolar carcinoma (BAC), adenocarcinoma (AC) with BAC component and AC without BAC component.

Methods

One hundred and six adenocarcinoma specimens which were followed up completely for 3 years, were obtained from 106 patients (45 men and 61 women) who underwent surgical resection for pathologically confirmed pulmonary adenocarcinoma in the Cancer Hospital of Tianjin Medical University, from June 2004 to December 2005. According to the recent 2004 World Health Organization (WHO) pathological classification criteria of lung cancer, lung adenocarcinomas were divided into three subgroups: pure BAC, AC with BAC component and AC without BAC component. The clinical data were retrospectively analyzed based on statistical methods. All data were analyzed using SPSS statistics software and Kaplan-Meier survival curves were constructed, meanwhile, we conducted a Log-rank test.

Results

The statistical analysis showed that no significant association was found among the three groups in gender and age; however, smoke index, tumor size, N stage, TNM stage, postoperative recurrence and metastasis had a statistically significant correlation among three groups (P < 0.01). The 3-year survival rates of the three groups were 96.4%, 61.0% and 40.5% respectively, which had a statistically significant difference. And the 3-year survival rate was significantly higher in the patients with pure BAC than in the patients with other types of lung adenocarcinomas (P < 0.01). In contrast to the other two groups (pure BAC and AC with BAC component), we found the evidence that the 3-year prognosis of lung adenocarcinoma without BAC component was worse than the two formers.

Conclusion

The three groups (pure BAC, AC with BAC component and AC without BAC component) have their own distinct clinicopathologic features respectively and completely different clinical prognosis. The strict distinction of the subtypes of lung adenocarcinoma can provide more reliable basis for scientific and comprehensive clinical treatment and contribute to assess the clinical prognosis effectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zhang CB, Xu ZY, Zhang K. Clinical analysis in patients with stage bronchioloalveolar carcinoma and adenocarcinoma. Chin J Clin Oncol (Chinese), 2004, 31: 33–35.

    Google Scholar 

  2. Travis WD, Garg K, Franklin MA, et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol, 2006, 1: 13–19.

    Article  Google Scholar 

  3. Laskin JJ, Sandler AB, Johnson DH. Redefining bronchioloalveolar carcinoma. Semin Oncol, 2005, 32: 329–335.

    Article  PubMed  Google Scholar 

  4. Wu YL, Jiang GL, Lu S, et al. Chinese consensus on bronchioloalveolar cell carcinoma. J Evidence-Based Med (Chinese), 2006, 6: 227–229.

    Google Scholar 

  5. Ge N, Li LY, Miao RY. Clinical analysis of 184 patients with bronchioloalveolar carcinoma. Oncol Prog (Chinese), 2008, 6: 269–277.

    Google Scholar 

  6. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol, 2005, 23: 3279–3287.

    Article  PubMed  Google Scholar 

  7. Terasaki H, Niki T, Matsuno Y, et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasivefoci, and immunohistochemical characterization. Am J Surg Pathol, 2003, 27: 937–951.

    Article  PubMed  Google Scholar 

  8. Jia B, Zhang ZF, Wang CL. Comparison of clinical features and prognostic facrors among different histological subtypes of lung adenocarcinoma: an analysis of 370 cases. Chin J Clin Oncol (Chinese), 2009, 36: 61–64.

    Google Scholar 

  9. Zhong XJ, Li DT, Li XL, et al. Comparison of the characteristics in recurrence and metastas is between bronchioloalveolar carcinoma and other lung adenocarcinomas. Cancer (Chinese), 2007, 26: 785–789.

    CAS  Google Scholar 

  10. Chen G, Liao ML. Clinical significance of new classification of subtypes of non-small cell lung cancer. Tumor (Chinese), 2006, 26: 1102–1104

    Google Scholar 

  11. Okada M, Nishio W, Sakamoto T, et al. Correlation between computed tomographic findings, bronchioloalveolarcarcinoma component, and biologic behavior of small-sizedlung adenocarcinomas. J Thoracic Cardiovascular Surgery, 2004, 127: 857–861.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhongli Zhan.

Additional information

Supported by a grant from the National Nature Sciences Foundation of China (No. 30770828).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, L., Guo, Y., Zhan, Z. et al. Comparative analysis of lung cancer with features of bronchioloalveolar carcinoma and other types of adenocarcinoma. Chin. -Ger. J. Clin. Oncol. 9, 13–16 (2010). https://doi.org/10.1007/s10330-009-0180-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-009-0180-x

Key words

Navigation